Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Secora Michael
Chief Financial Officer at RECURSION PHARMACEUTICALS. Filing since 13 Jun 2023.
CIK 0001855980
Company
Date
Role
Action
Shares
Amount
Of holding
RXRX
RECURSION PHARMACEUTICALS, INC.
13 Nov 2024
Chief Financial Officer
Sold on a plan
15,000
$114.88K
1.0%
RXRX
RECURSION PHARMACEUTICALS, INC.
12 Nov 2024
Chief Financial Officer
Sold on a plan
15,000
$114.63K
1.0%
RXRX
RECURSION PHARMACEUTICALS, INC.
9 Oct 2024
Chief Financial Officer
Sold on a plan
15,000
$95.37K
1.0%
RXRX
RECURSION PHARMACEUTICALS, INC.
8 Oct 2024
Chief Financial Officer
Sold on a plan
15,000
$94.76K
1.0%
RXRX
RECURSION PHARMACEUTICALS, INC.
11 Sep 2024
Chief Financial Officer
Sold on a plan
15,000
$94.73K
1.1%
RXRX
RECURSION PHARMACEUTICALS, INC.
10 Sep 2024
Chief Financial Officer
Sold on a plan
15,000
$92.50K
1.1%
RXRX
RECURSION PHARMACEUTICALS, INC.
14 Aug 2024
Chief Financial Officer
Sold on a plan
15,000
$95.25K
1.1%
RXRX
RECURSION PHARMACEUTICALS, INC.
13 Aug 2024
Chief Financial Officer
Sold on a plan
15,000
$95.18K
1.1%
RXRX
RECURSION PHARMACEUTICALS, INC.
10 Jul 2024
Chief Financial Officer
Sold on a plan
15,000
$108.58K
1.1%
RXRX
RECURSION PHARMACEUTICALS, INC.
9 Jul 2024
Chief Financial Officer
Sold on a plan
15,000
$109.78K
1.1%
RXRX
RECURSION PHARMACEUTICALS, INC.
14 Jun 2024
Chief Financial Officer
Sold on a plan
15,000
$139.08K
1.2%
RXRX
RECURSION PHARMACEUTICALS, INC.
13 Jun 2024
Chief Financial Officer
Sold on a plan
15,000
$139.80K
1.2%
RXRX
RECURSION PHARMACEUTICALS, INC.
17 Apr 2024
Chief Financial Officer
Sold on a plan
23,124
$175.35K
1.8%
RXRX
RECURSION PHARMACEUTICALS, INC.
16 Apr 2024
Chief Financial Officer
Sold on a plan
25,000
$191.66K
2.0%
RXRX
RECURSION PHARMACEUTICALS, INC.
13 Mar 2024
Chief Financial Officer
Sold on a plan
25,000
$275.82K
2.0%
RXRX
RECURSION PHARMACEUTICALS, INC.
12 Mar 2024
Chief Financial Officer
Sold on a plan
25,000
$261.38K
2.1%
RXRX
RECURSION PHARMACEUTICALS, INC.
14 Feb 2024
Chief Financial Officer
Sold on a plan
25,000
$261.42K
2.1%
RXRX
RECURSION PHARMACEUTICALS, INC.
13 Feb 2024
Chief Financial Officer
Sold on a plan
25,000
$246.56K
2.1%
RXRX
RECURSION PHARMACEUTICALS, INC.
17 Jan 2024
Chief Financial Officer
Sold on a plan
25,000
$256.35K
2.5%
RXRX
RECURSION PHARMACEUTICALS, INC.
16 Jan 2024
Chief Financial Officer
Sold on a plan
25,000
$261.16K
2.5%
RXRX
RECURSION PHARMACEUTICALS, INC.
13 Dec 2023
Chief Financial Officer
Sold on a plan
25,000
$189.77K
2.5%
RXRX
RECURSION PHARMACEUTICALS, INC.
12 Dec 2023
Chief Financial Officer
Sold on a plan
25,000
$184.87K
2.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
15 Nov 2023
Chief Financial Officer
Sold on a plan
25,000
$182.99K
2.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
14 Nov 2023
Chief Financial Officer
Sold on a plan
25,000
$157.94K
2.6%
RXRX
RECURSION PHARMACEUTICALS, INC.
11 Oct 2023
Chief Financial Officer
Sold on a plan
25,000
$171.31K
2.7%
RXRX
RECURSION PHARMACEUTICALS, INC.
10 Oct 2023
Chief Financial Officer
Sold on a plan
25,000
$176.76K
2.7%
RXRX
RECURSION PHARMACEUTICALS, INC.
13 Sep 2023
Chief Financial Officer
Sold on a plan
25,000
$217.32K
2.7%
RXRX
RECURSION PHARMACEUTICALS, INC.
12 Sep 2023
Chief Financial Officer
Sold on a plan
25,000
$210.63K
2.8%
RXRX
RECURSION PHARMACEUTICALS, INC.
16 Aug 2023
Chief Financial Officer
Sold on a plan
25,000
$222.52K
2.8%
RXRX
RECURSION PHARMACEUTICALS, INC.
15 Aug 2023
Chief Financial Officer
Sold on a plan
25,000
$231.79K
2.9%
RXRX
RECURSION PHARMACEUTICALS, INC.
19 Jul 2023
Chief Financial Officer
Sold on a plan
25,000
$388.35K
2.9%
RXRX
RECURSION PHARMACEUTICALS, INC.
18 Jul 2023
Chief Financial Officer
Sold on a plan
25,000
$340.80K
2.9%
RXRX
RECURSION PHARMACEUTICALS, INC.
14 Jun 2023
Chief Financial Officer
Sold on a plan
25,000
$251.84K
3.0%
RXRX
RECURSION PHARMACEUTICALS, INC.
13 Jun 2023
Chief Financial Officer
Sold on a plan
25,000
$248.31K
3.0%
34 decisions on file.
